## Abstract ## Objective To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS) and altitude headache development within 24 hours of ascent, we designed a doubleβblind, randomized, clinical trial. ## Methods A prospective, doubleβblind, randomized, placeboβcontrolled
β¦ LIBER β¦
PREVENTION OF ACUTE MOUNTAIN SICKNESS
β Scribed by A. D. Wright
- Book ID
- 114738049
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 109 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0269-4727
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sumatriptan for prevention of acute moun
β
Sirous Jafarian; Farzam Gorouhi; Shabnam Salimi; Jamshid Lotfi
π
Article
π
2007
π
John Wiley and Sons
π
English
β 95 KB
π 2 views
Prevention of Acute Mountain Sickness in
β
Laxmi Vilas Ghimire; Matiram Pun
π
Article
π
2007
π
Elsevier Science
π
English
β 61 KB
Reply to Prevention of Acute Mountain Si
β
Peter Hillenbrand; Anil K. Pahari; Yuen Soon; Deepak Subedi; Rajan Bajracharaya;
π
Article
π
2007
π
Elsevier Science
π
English
β 566 KB
Acetazolamide for the Prevention of Acut
β
Neil D. Ritchie; Amy V. Baggott; W. T. Andrew Todd
π
Article
π
2012
π
John Wiley and Sons
π
English
β 812 KB
Prevention of Acute Mountain Sickness by
β
Peter Hillenbrand; Anil K. Pahari; Yuen Soon; Deepak Subedi; Rajan Bajracharya;
π
Article
π
2006
π
Elsevier Science
π
English
β 144 KB
Spironolactone Does Not Prevent Acute Mo
β
Buddha Basnyat; Peter S. Holck; Matiram Pun; Stephen Halverson; Piotr Szawarski;
π
Article
π
2011
π
Elsevier Science
π
English
β 564 KB
## Objectives: Over the last 20 years a number of small trials have reported that spironolactone effectively prevents acute mountain sickness (ams), but to date there have been no large randomized trials investigating the efficacy of spironolactone in prevention of ams. hence, a prospective, double